1. Home
  2. CTXR vs FBGL Comparison

CTXR vs FBGL Comparison

Compare CTXR & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • FBGL
  • Stock Information
  • Founded
  • CTXR 2007
  • FBGL 1996
  • Country
  • CTXR United States
  • FBGL Singapore
  • Employees
  • CTXR N/A
  • FBGL N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • CTXR Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • CTXR 14.6M
  • FBGL 12.4M
  • IPO Year
  • CTXR N/A
  • FBGL 2025
  • Fundamental
  • Price
  • CTXR $0.84
  • FBGL $0.74
  • Analyst Decision
  • CTXR Strong Buy
  • FBGL
  • Analyst Count
  • CTXR 2
  • FBGL 0
  • Target Price
  • CTXR $54.50
  • FBGL N/A
  • AVG Volume (30 Days)
  • CTXR 679.0K
  • FBGL 407.7K
  • Earning Date
  • CTXR 05-13-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • CTXR N/A
  • FBGL N/A
  • EPS Growth
  • CTXR N/A
  • FBGL N/A
  • EPS
  • CTXR N/A
  • FBGL 0.04
  • Revenue
  • CTXR N/A
  • FBGL $15,607,369.00
  • Revenue This Year
  • CTXR N/A
  • FBGL N/A
  • Revenue Next Year
  • CTXR N/A
  • FBGL N/A
  • P/E Ratio
  • CTXR N/A
  • FBGL $16.99
  • Revenue Growth
  • CTXR N/A
  • FBGL 25.78
  • 52 Week Low
  • CTXR $0.81
  • FBGL $0.44
  • 52 Week High
  • CTXR $26.25
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 28.63
  • FBGL N/A
  • Support Level
  • CTXR $0.81
  • FBGL N/A
  • Resistance Level
  • CTXR $1.02
  • FBGL N/A
  • Average True Range (ATR)
  • CTXR 0.09
  • FBGL 0.00
  • MACD
  • CTXR 0.01
  • FBGL 0.00
  • Stochastic Oscillator
  • CTXR 10.09
  • FBGL 0.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.

Share on Social Networks: